249 related articles for article (PubMed ID: 14680421)
1. Impact of formularies on clinical innovation.
Goodwin FK
J Clin Psychiatry; 2003; 64 Suppl 17():11-4. PubMed ID: 14680421
[TBL] [Abstract][Full Text] [Related]
2. The changing environment for technological innovation in health care.
Goodman CS; Gelijns AC
Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
[TBL] [Abstract][Full Text] [Related]
3. Decrease hassles and costs by integrating your plans' formularies.
Domino FJ; Baldor RA
Fam Pract Manag; 1998; 5(10):27-30. PubMed ID: 10344926
[No Abstract] [Full Text] [Related]
4. Impact of formulary restrictions on patient safety.
Lazarus A
Physician Exec; 2005; 31(4):42-4. PubMed ID: 16285169
[No Abstract] [Full Text] [Related]
5. Weighing the evidence: trends in managed care formulary decision making.
de Lissovoy G
J Clin Psychiatry; 2003; 64 Suppl 17():29-32. PubMed ID: 14680425
[TBL] [Abstract][Full Text] [Related]
6. How effectively do managed care organizations influence prescribing and dispensing decisions?
Carroll NV
Am J Manag Care; 2002 Dec; 8(12):1041-54. PubMed ID: 12500881
[TBL] [Abstract][Full Text] [Related]
7. Dermatologic formularies in the managed care setting.
James WD
Arch Dermatol; 1996 Sep; 132(9):1120-1. PubMed ID: 8795559
[TBL] [Abstract][Full Text] [Related]
8. Managed care's atypical response. New antipsychotics show promise, but are they getting into enough hands?
Waldron T
Behav Healthc Tomorrow; 1999 Apr; 8(2):28-31. PubMed ID: 10351297
[No Abstract] [Full Text] [Related]
9. Budget impact of tegaserod on a managed care organization formulary.
Bloom MA; Barghout V; Kahler KH; Bentkover J; Kurth H; Gralnek IM; Spiegel BM
Am J Manag Care; 2005 Apr; 11(1 Suppl):S27-34. PubMed ID: 15926761
[TBL] [Abstract][Full Text] [Related]
10. Unlocking the secrets of restrictive formularies.
Kassberg M
Manag Care; 1994 Dec; 3(12):15-8, 20-1. PubMed ID: 10154852
[No Abstract] [Full Text] [Related]
11. Use of a geriatric formulary in long-term care.
Babington MA
Med Interface; 1997 Jan; 10(1):87-8, 115. PubMed ID: 10164509
[TBL] [Abstract][Full Text] [Related]
12. Cut pharmaceutical costs, but mind the legal dangers.
Abood RR
Manag Care; 1997 Aug; 6(8):47-8, 51-4. PubMed ID: 10170246
[No Abstract] [Full Text] [Related]
13. Use of health-related quality of life information in managed care formulary decision-making.
Wu WK; Sause RB; Zacker C
Res Social Adm Pharm; 2005 Dec; 1(4):579-98. PubMed ID: 17138497
[TBL] [Abstract][Full Text] [Related]
14. Injectable drugs: the new frontier in pharmacy management.
Rodgers JR
Am J Manag Care; 2003 Jun; Suppl Decision Maker News():5-8. PubMed ID: 12866365
[No Abstract] [Full Text] [Related]
15. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
Sneed RC; May WL; Stencel C
Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
[TBL] [Abstract][Full Text] [Related]
16. Ethical principles for psychiatric administrators: the challenge of formularies.
Moffic HS
Psychiatr Q; 2006; 77(4):319-27. PubMed ID: 16927163
[TBL] [Abstract][Full Text] [Related]
17. Managed care cost-containment strategies and their impact on physician prescribing and treatment of depression. Based on a presentation by Robert K. Schreter, MD.
Am J Manag Care; 2000 Feb; 6(2 Suppl):S47-52. PubMed ID: 10977428
[TBL] [Abstract][Full Text] [Related]
18. Medication restrictions: feeling the side effects.
Fitzpatrick C
Behav Healthc Tomorrow; 2001 Oct; 10(5):14-7, 39-40. PubMed ID: 11594068
[No Abstract] [Full Text] [Related]
19. The impact of managed care on pharmacy practice.
Schafermeyer KW
Pharm Pract Manag Q; 2000 Jan; 19(4):99-116. PubMed ID: 10787569
[TBL] [Abstract][Full Text] [Related]
20. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
MacEachern L
Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
